Ccbr Brasil Centro de Analises e Pesquisas Clinicas Ltda

Rio de Janeiro 22271-100

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetes Type 2, Diabetes, Type I

Studies at this site

• Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes — Completed
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up — Completed
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes — Completed
• Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma — Stopped early